Network Voices Conversations: Dr. Bishal Gyawali
Patient Working Group members Beverley Riediger and Dan Murphy speak with Dr. Bishal Gyawali about common sense oncology.
We all know the importance of delivering the right treatment to the right patient at the right time.
But what about choosing the right dose and the right duration?
In this episode, MOHCCN Patient Working Group members Beverley Riediger and Dan Murphy speak with Dr. Bishal Gyawali about common sense oncology—an approach that helps patients and clinicians choose treatments that reduce toxicity, lower costs and optimize quality of life.
They explore why common sense oncology is essential to precision medicine, how researchers can measure effects on quality of life and what questions patients and caregivers should ask when considering a new treatment.
Watch the full video
Network Voices Conversations:
Network Voices Conversations feature interviews with MOHCCN researchers and clinicians led by Patient Working Group members on the topics that matter to them. Each conversation goes in-depth on the how our guest is contributing to advancing life-changing cancer research, the future of precision medicine and how the Marathon of Hope Cancer Centres Network is bringing new hope to cancer patients and clinicians across Canada.
Check out all the episodes in our Network Voices Conversations series.
Related Team Members
-
Bishal
Researcher
Gyawali -
Beverley
Working Group Member
Riediger -
Dan
Working Group Member
Murphy
Related Project
Related News
-
Network Voices Conversations: Dr. Samantha Pollard
Patient Working Group members, James Pereira and Sheilah Brukewich, chat with Dr. Samantha Pollard about why patient values should be at the centre of precision oncology. -
Network Voices Conversations: Dan Loos, Biobank NL
In this episode, Patient Working Group members, Jennifer Coish and Darrin Park, chat with Dan Loos, the coordinator of BioBank NL, about all things biobanking. -
Q&A with Dr. Sevtap Savas: Collaborating with patients to transform cancer research
Dr. Sevtap Savas is a contributor to the MOHCCN’s Atlantic Cancer Consortium (ACC) working on a project focused on colorectal cancer while also leading the Patient Advisory Committee which helps guide... -
Q&A with Dr. Versha Banerji: Turning perseverance into progress for patients
Dr. Versha Banerji is a hematologist, clinician-scientist, and translational researcher based in Winnipeg. Through the MOHCCN, she leads a patient-centred research program focused on improving access ...